Immunomic TherapeuticsImmunomic Therapeutics
Immunomic TherapeuticsImmunomic Therapeutics
  • Pipeline
  • Partnerships
  • Clinical Trials
    • ITI-1000: Glioblastoma Multiforme
    • ITI-1001: Glioblastoma Multiforme
    • ITI-3000: Merkel Cell Carcinoma
  • Team
  • Careers
  • Media
  • Contact Us
  • Pipeline
  • Partnerships
  • Clinical Trials
    • ITI-1000: Glioblastoma Multiforme
    • ITI-1001: Glioblastoma Multiforme
    • ITI-3000: Merkel Cell Carcinoma
  • Team
  • Careers
  • Media
  • Contact Us

Blog

  • Articles
  • Blog
  • Events
  • Featured
  • Highlights
  • Posters
  • Press
  • Press Releases
  • Uncategorized

Immunomic Therapeutics’ CEO to present at the 13th Annual Biotech Showcase Digital Event

by Sara Solt in Featured, Press, Press Releases
January 05, 2021 08:05 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today that the company will present at the 13th Annual ...
Read More

ITI Executives and Board Members of WhyWeVax™ Discuss COVID-19 Vaccine Issues with Fox News and CDC’s ACIP Committee

by Sara Solt in Featured, Press, Press Releases
December 09, 2020 04:05 PM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, and WhyWeVax™ (WWV), ...
Read More

BIO CEO & Investor Digital Conference, Feb. 16-18, 2021

by Sara Solt in Events, Past Events
ITI will be presening at the BIO CEO & Investor Digital Conference, February 16-18, 2021 For more than 20 years, the BIO CEO & Investor Conference has fueled biotech industry ...
Read More

Biotech Showcase Digital, Jan. 11-15, 2021

by Sara Solt in Events, Past Events
ITI will be presenting at the Biotech Showcase January 11–15, 2021, Delivered Digitally, US Pacific Standard Time DISCOVER. INVEST. CURE. – DIGITAL INVESTOR CONFERENCE It's all happening here! Connecting investors ...
Read More

ITI’s CEO to Present at the 2nd Annual Glioblastoma Drug Development Summit

by Sara Solt in Featured, Highlights, Press, Press Releases
December 01, 2020 08:05 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI) announced today that it will be presenting at the 2nd Annual Glioblastoma Drug Development Virtual Summit. ...
Read More

ITI and CoImmune Enter into Partnership to Manufacture A Novel Experimental Cell Therapy for GBM

by Sara Solt in Featured, Highlights, Press, Press Releases
November 19, 2020 04:05 PM Eastern Standard Time ROCKVILLE, Md. & DURHAM, N.C.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, ...
Read More

Society for Immunotherapy of Cancer (SITC) 2020 Poster Presentation

by Sara Solt in Posters
Poster Title: LAMP1 targeting of the large T antigen of Merkel cell polyomavirus elicits potent CD4+ T cell responses and prevents tumor growth Presentation Date: 11/11/2020 - 11/14/2020, 9:00 am ...
Read More

Longwood Healthcare Leaders Meeting, Virtual, April 5-6, 2021

by Sara Solt in Events, Past Events
Longwood Healthcare Leaders meeting, April 5-6, 2021, centered on MIT’s Koch Institute via web conference with leading biopharma CEOs, heads of R&D, top academic researchers, and healthcare investors, co-hosted by ...
Read More

Society for Neuro-oncology Annual Meeting, Boston, MA November 18-21, 2021

by Sara Solt in Past Events
The SNO annual meeting is the world’s largest neuro-oncology conference, attracting over 2400 researchers and clinician-scientists from all neuro-oncology disciplines, professionals, and interests from more than 40 countries.  The meeting ...
Read More

SITC Annual Meeting and Pre-Conference Program 2021, Washington, DC, Nov. 10-14, 2021

by Sara Solt in Blog
The Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting & Pre-Conference Programs (SITC 2021) will take place on Nov. 10–14, 2021, at the Walter E. Washington Convention Center in Washington, ...
Read More

ESMO Congress 2021, Paris, France, Sept 17-21, 2021

by Sara Solt in Past Events
The ESMO Congress is the yearly appointment in Europe for nearly 30’000 clinicians, researchers, oncology nurses, patient advocates, journalists, and representatives of the pharmaceutical industry from all over the world ...
Read More

World Vaccine Congress Washington 2021, Date TBD

by Sara Solt in Blog
World Vaccine Congress remains the industry’s definitive vaccine industry event for major vaccine players and their respective senior-level representatives More detailed information to come.
Read More
1
2345
…678910…
111213141516171819202122232425
26
← Previous pageNext page →

Content
  • Pipeline
  • Partnerships
  • Team
  • Media
  • Contact Us
Careers
  • Careers
  • Compensation & Benefits
  • Culture & Beliefs
Policies
  • Expanded Access Policy
  • Privacy Policy
Social
  • Facebook
  • X / Twitter
  • Youtube
Telephone

+1.301.968.3501

Address

15010 Broschart Road

Rockville, MD 20850

© 2020 Immunomic Therapeutics, Inc. All Rights Reserved.